Government Supported Benefits References
		Home
		References
		Pub Med
		HubMed

ARTICLES : MEDICARE PART D IN GENERAL

1: Saleh SS, Weller W, Hannan E. The effect of insurance type on prescription drug use and expenditures among elderly Medicare beneficiaries. J Health Hum Serv Adm. 2007 Summer;30(1):50-74. PMID: 17557696 [PubMed - in process]

2: Thomas CP, Sussman J; Massachusettes Health Policy Forum; Massachusetts Medicaid Policy Institute. Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries. Issue Brief (Mass Health Policy Forum). 2007 May 30;(32):1-32. PMID: 17546802 [PubMed - indexed for MEDLINE]

3: Gold M. Medicare Advantage In 2006-2007: What Congress Intended? Health Aff (Millwood). 2007 May 15; [Epub ahead of print] PMID: 17504767 [PubMed - as supplied by publisher]

4: Cawley JH, Whitford AB. Improving the design of competitive bidding in Medicare Advantage. J Health Polit Policy Law. 2007 Apr;32(2):317-47. PMID: 17463410 [PubMed - in process]

5: Boyd ST, Boyd LC, Zillich AJ. Medication therapy management survey of the prescription drug plans. J Am Pharm Assoc (2003). 2006 Nov-Dec;46(6):692-9. PMID: 17176684 [PubMed - indexed for MEDLINE]

6: Touchette DR, Burns AL, Bough MA, Blackburn JC. Survey of medication therapy management programs under Medicare part D. J Am Pharm Assoc (2003). 2006 Nov-Dec;46(6):683-91. PMID: 17176683 [PubMed - indexed for MEDLINE]

7: Ashkenazy R, Abrahamson MJ. Medicare coverage for patients with diabetes. A national plan with individual consequences. J Gen Intern Med. 2006 Apr;21(4):386-92. PMID: 16686819 [PubMed - indexed for MEDLINE]

8: Cubanski J, Neuman P. Status report on Medicare Part D enrollment in 2006: analysis of plan-specific market share and coverage. Health Aff (Millwood). 2007 Jan-Feb;26(1):w1-12. Epub 2006 Nov 21. PMID: 17118944 [PubMed - indexed for MEDLINE]

9: Peters CP. Medicare advantage SNPs: a new opportunity for integrated care? NHPF Issue Brief. 2005 Nov 11;(808):1-18. PMID: 16296563 [PubMed - indexed for MEDLINE] MEDICAID AND OPIOID ABUSE

10: Inciardi JA, Surratt HL, Kurtz SP, Cicero TJ. Mechanisms of prescription drug diversion among drug-involved club- and street-based populations. Pain Med. 2007 Mar;8(2):171-83. PMID: 17305688 [PubMed - indexed for MEDLINE]

11: Havens JR, Talbert JC, Walker R, Leedham C, Leukefeld CG. Trends in controlled-release oxycodone (OxyContin) prescribing among Medicaid recipients in Kentucky, 1998-2002. J Rural Health. 2006 Summer;22(3):276-8. PMID: 16824176 [PubMed - indexed for MEDLINE]

12: Williams B. Too much medicine? Tenn Med. 2006 Apr;99(4):19-23. No abstract available. PMID: 16704125 [PubMed - indexed for MEDLINE]

13: Manchikanti L, Fellows B, Damron KS, Pampati V, McManus CD. Prevalence of illicit drug use among individuals with chronic pain in the Commonwealth of Kentucky: an evaluation of patterns and trends. J Ky Med Assoc. 2005 Feb;103(2):55-62. PMID: 15751456 [PubMed - indexed for MEDLINE]

14: Mullins CR, Wild TL. Pain management in a long-term care facility: compliance with JCAHO standards. J Pain Palliat Care Pharmacother. 2003;17(2):63-70. PMID: 14649389 [PubMed - indexed for MEDLINE]

15: Elwood WN. Sticky business: patterns of procurement and misuse of prescription cough syrup in Houston. J Psychoactive Drugs. 2001 Apr-Jun;33(2):121-33. Review. PMID: 11476259 [PubMed - indexed for MEDLINE] SCOTT FISHMAN ARTICLES

16: Fishman SM. Recognizing pain management as a human right: a first step. Anesth Analg. 2007 Jul;105(1):8-9. No abstract available. PMID: 17578943 [PubMed - in process]

17: Fishman SM. Aspirin, NSAIDs, and COX-2 Inhibitors, Glucosamine and Chondroitin, Neurontin for Pain, Antidepressants for Pain, Topical Analgesics:Ben Gay versus Capsaicin. J Pain Palliat Care Pharmacother. 2007;21(1):91-7. PMID: 17430840 [PubMed - in process]

18: Chan KT, Fishman SM. Legal aspects of chronic opioid therapy. Curr Pain Headache Rep. 2006 Dec;10(6):426-30. Review. PMID: 17087867 [PubMed - indexed for MEDLINE]

19: Wilsey BL, Fishman SM, Ogden C. Prescription opioid abuse in the emergency department. J Law Med Ethics. 2005 Winter;33(4):770-82. No abstract available. PMID: 16686246 [PubMed - indexed for MEDLINE]

20: Fishman SM. Pain and politics: DEA, Congress, and the courts, oh my! Pain Med. 2006 Jan-Feb;7(1):87-8. No abstract available. PMID: 16533207 [PubMed - indexed for MEDLINE]

21: Fishman SM. Addiction. J Pain Palliat Care Pharmacother. 2005;19(2):41-3. Review. PMID: 16061461 [PubMed - indexed for MEDLINE] PERRY FINE ARTICLE ON USE OF OPIOIDS IN THE ELDERLY

22: Hadjistavropoulos T, Herr K, Turk DC, Fine PG, Dworkin RH, Helme R, Jackson K, Parmelee PA, Rudy TE, Lynn Beattie B, Chibnall JT, Craig KD, Ferrell B, Ferrell B, Fillingim RB, Gagliese L, Gallagher R, Gibson SJ, Harrison EL, Katz B, Keefe FJ, Lieber SJ, Lussier D, Schmader KE, Tait RC, Weiner DK, Williams J. An interdisciplinary expert consensus statement on assessment of pain in older persons. Clin J Pain. 2007 Jan;23(1 Suppl):S1-43. PMID: 17179836 [PubMed - indexed for MEDLINE]

23: J Gen Intern Med. 2006 Apr;21(4):386-92. Medicare coverage for patients with diabetes. A national plan with individual consequences. Ashkenazy R, Abrahamson MJ. Beth Israel Deaconess Medical Center, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA. rebecca_ashkenazy@yahoo.com The prevalence of diabetes in the U.S. Medicare population is growing at an alarming rate. From 1980 to 2004, the number of people aged 65 or older with diagnosed diabetes increased from 2.3 million to 5.8 million. According to the Centers for Medicare and Medicaid (CMS), 32% of Medicare spending is attributed to the diabetes population. Since its inception, Medicare has expanded medical coverage of monitoring devices, screening tests and visits, educational efforts, and preventive medical services for its diabetic enrollees. However, oral antidiabetic agents and insulin were excluded from reimbursement. In 2003, Congress passed the Medicare Modernization Act that includes a drug benefit to be administered either through Medicare Advantage drug plans or privately sponsored prescription drug plans for implementation in January 2006. In this article we highlight key patient and drug plan characteristics and resources that providers may focus upon to assist their patients choose a coverage plan. Using a case example, we illustrate the variable financial impact the adoption of Medicare part D may have on beneficiaries with diabetes due to their economic status. We further discuss the potential consequences the legislation will have on diabetic patients enrolled in Medicare, their providers, prescribing strategies, and the diabetes market. PMID: 16686819 [Pubmed - indexed for MEDLINE]